Redwood Investment Management, LLC Gilead Sciences, Inc. Transaction History

Redwood Investment Management, LLC

$1.16 Billion
Q2 2024

A detailed history of Redwood Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Redwood Investment Management, LLC holds 32,136 shares of GILD stock, worth $2.83 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

32,136

Previous 29,260 9.83%

Holding current value

$2.83 Million

Previous $2.14 Million 2.89%

% of portfolio

0.19%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $181,619 - $209,602	2,876 Added 9.83%	32,136 $2.21 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $42,733 - $52,112	597 Added 2.08%	29,260 $2.14 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $157,677 - $178,809	-2,152 Reduced 6.98%	28,663 $2.32 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.28 Million - $2.49 Million	30,815 New	30,815 $2.31 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $1.89 Million - $2.15 Million	24,436 New	24,436 $2.03 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $1.3 Million - $1.63 Million	-22,399 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $200,608 - $227,694	3,092 Added 16.01%	22,399 $1.63 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $23,420 - $25,268	-346 Reduced 1.76%	19,307 $1.35 Million
Q2 2021 Aug 17, 2021	BUY	$63.47 - $69.35 $233,125 - $254,722	3,673 Added 22.98%	19,653 $1.29 Million
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $7,980 - $9,105	133 Added 0.84%	15,980 $1.03 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $41,460 - $47,305	691 Added 4.56%	15,847 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $255,548 - $291,185	4,511 Added 42.38%	15,156 $883,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $190,398 - $239,393	3,066 Added 40.45%	10,645 $673,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $548,264 - $636,636	7,579 New	7,579 $583,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $372,585 - $477,228	-5,949 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $61,681 - $67,847	1,001 Added 20.23%	5,949 $387,000
Q3 2019 Nov 18, 2019	BUY	$62.51 - $69.0 $47,570 - $52,509	761 Added 18.18%	4,948 $314,000
Q2 2019 Aug 15, 2019	BUY	$61.87 - $69.38 $43,803 - $49,121	708 Added 16.91%	4,895 $331,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $43,803 - $49,121	-708 Reduced 14.46%	4,187 $272,000
Q1 2019 May 16, 2019	BUY	$62.53 - $70.05 $261,813 - $293,299	4,187 New	4,187 $272,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $226,116 - $295,065	-3,735 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $24,235 - $26,832	340 Added 10.01%	3,735 $288,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $34,970 - $40,791	539 Added 18.87%	3,395 $241,000
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $208,031 - $253,612	2,856 New	2,856 $215,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investment Management, LLC with notifications on news.

Account

Redwood Investment Management, LLC Gilead Sciences, Inc. Transaction History